Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 46 (4) , 947-958
- https://doi.org/10.1016/s0360-3016(99)00500-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Malignant cerebral glioma--I: Survival, disability, and morbidity after radiotherapyBMJ, 1996
- Univariate and multivariate statistical analysis of high-grade gliomas: The relationship of radiation dose and other prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Radiotherapy for high grade gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Topographic anatomy and CT correlations in the untreated glioblastoma multiformeJournal of Neurosurgery, 1988
- Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group studyCancer, 1983
- Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volumeInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Therapeutic irradiation and brain injuryInternational Journal of Radiation Oncology*Biology*Physics, 1980
- An analysis of dose-effect relationship in the radiotherapy of malignant gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978